How can MRD and disease be assessed in routine practice?
ENDEAVOUR, ASPIRE and TOURMALINE-MM1 trial results for multiple myeloma
Features of high-risk multiple myeloma and how to treat it
Overview of a Phase II clinical trial of isatuximab
Myeloma 2016: Panel discussion on the application of genomics studies
Leif Bergsagel et al.